Skyrizi Archives -

AbbVie’s IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into

AbbVie’s Skyrizi beats IL-23 rivals to Crohn’s disease approval

https://pharmaphorum.com/news/abbvies-skyrizi-beats-il-23-rivals-to-crohns-disease-approval/

AbbVie is in a race against time as US patent expiry of its Humira inflammatory diseases blockbuster looms

AbbVie scores crucial phase 3 wins with Humira follow-up Skyrizi

https://pharmaphorum.com/news/abbvie-scores-crucial-phase-3-wins-with-humira-follow-up-skyrizi/

AbbVie’s rheumatoid arthritis drug upadacitinib is at the top of a new list of drugs due to launch

Seven future blockbuster drugs to look out for in 2019

https://pharmaphorum.com/news/seven-future-blockbuster-drugs-to-look-out-for-in-2019/

Skyrizi